Aparna Kalyan

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers”.

SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers

Journal of Clinical Oncology(2024)10.1200/jco-24-01383

N/A

1.1DataRank · unranked

51 citations

Gentry Teng King, Sarah Colby, Aaron J. Scott, Mitesh J. Borad, Laura W. Goff +17 more

A Phase 2 study of Savolitinib in Patients with MET Amplified Metastatic Colorectal Cancer

Journal of Gastrointestinal Cancer(2024)10.1007/s12029-024-01156-x

N/A

0.227DataRank · unranked

3 citations

Ashley Moyer, Melissa Lowe, Emily Bolch, Jeremy Kortmansky, May Cho +5 more

SWOG 1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.lba490

N/A

0DataRank · unranked

99 citations

Katherine A. Guthrie, Aaron J. Scott, Mitesh J. Borad, Laura W. Goff, Khalid Matin +15 more

Radioembolization for Intermediate-Stage Hepatocellular Carcinoma Maintains Liver Function and Permits Systemic Therapy at Progression

Journal of Vascular and Interventional Radiology(2023)10.1016/j.jvir.2022.11.036

N/A

0DataRank · unranked

13 citations

Ahmed Gabr, Pouya Entezari, Andrew C. Gordon, Ahsun Riaz, Kush Desai +6 more

The room where it happens: addressing diversity, equity, and inclusion in National Clinical Trials Network clinical trial leadership

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad121

N/A

0DataRank · unranked

9 citations

Barbara Burtness, May Cho, Jaydira Del Rivero, Deborah B. Doroshow, Kathryn Hitchcock +12 more

Randomized, phase II selection study of ramucirumab and paclitaxel versus FOLFIRI in refractory small bowel adenocarcinoma: SWOG S1922.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps784

N/A

0DataRank · unranked

1 citations

Katherine A. Guthrie, Mohamed E. Salem, Katrina S. Pedersen, Aparna Kalyan, Sarah Colby +7 more

Yttrium-90 Radiation Segmentectomy for Treatment of Neuroendocrine Liver Metastases

Journal of Vascular and Interventional Radiology(2024)10.1016/j.jvir.2024.11.003

N/A

0DataRank · unranked

9 citations

Rohan Savoor, Sheetal Kircher, Aparna Kalyan, Al B. Benson, Elias Hohlastos +5 more

Radiation Segmentectomy and Modified Radiation Lobectomy for Unresectable Early-Stage Intrahepatic Cholangiocarcinoma

Journal of Vascular and Interventional Radiology(2024)10.1016/j.jvir.2024.12.016

N/A

0DataRank · unranked

6 citations

Muhamad Serhal, Andrew C. Gordon, Ahmed Gabr, Aparna Kalyan, Laura Kulik +6 more

A Phase 2 study of Savolitinib in Patients with MET Amplified Metastatic Colorectal Cancer

Carolina Digital Repository (University of North Carolina at Chapel Hill)(2024)10.17615/yy24-c083

N/A

0DataRank · unranked

0 citations

Jingquan Jia, Aparna Kalyan, Emily Bolch, May Cho, Melissa Lowe +5 more

Phase Ib study of anetumab ravtansive in combination with immunotherapy or immunotherapy plus chemotherapy in mesothelin-enriched advanced pancreatic adenocarcinoma: NCI10208.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4136

N/A

0DataRank · unranked

12 citations

Anup Kasi, Laith Abushahin, Dana B. Cardin, Heinz‐Josef Lenz, Farshid Dayyani +15 more

Escalated Segmental and Modified Radiation Lobectomy Dosing for Yttrium-90 Radioembolization of Liver-Dominant Metastatic Colorectal Cancer: 10-year Outcomes

Clinical Colorectal Cancer(2025)10.1016/j.clcc.2025.02.005

N/A

0DataRank · unranked

2 citations

Saad Abu Zahra, Muhamad Serhal, Sheetal Kircher, Aparna Kalyan, Kent T. Sato +5 more

Randomized phase II selection study of ramucirumab and paclitaxel versus FOLFIRI in refractory small bowel adenocarcinoma: SWOG S1922.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps643

N/A

0DataRank · unranked

2 citations

Katherine A. Guthrie, Mohamed E. Salem, Katrina S. Pedersen, Aparna Kalyan, Shay Bellasea +2 more